CEO: Joseph W. Turgeon

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Spectrum Pharmaceuticals Inc is a biotechnology company in the United States. It develops drugs to cure serious diseases such as chemotherapy-induced neutropenia in patients with breast cancer.


Key numbers

Market Capitalization:863656500
Shares Outstanding: 104055000
Float: 97577888.415
Next Earning Date:2020-03-04
TTm EPS: -1.1301
TTm Dividend Rate:
200 days moving average:8.86
50 days moving average: 8.26
One day percent Change: 5.73



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,